A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
NYS Entity Status
NYS Filing Date
AUGUST 15, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - GROVE & BAILEY, LTD.
Around the Web
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
- African sound at the fore of Stern Grove
By Brandon Yu - Tuesday Aug 1, 2017
What keeps the Stern Grove Festival — the annual free summer concert series at the Sigmund Stern Grove amphitheater, celebrating its 80th anniversary this year — a valued spotlight for live music is its vigilance in programming not only big-name, beloved performers (such as season opener Kool & the Gang) but also introducing lesser-known musical gems.The duo is a blind couple from Mali who have, since forming in the 1970s, brought their blend of Afro blues to stages around the world, from Coachella to Glastonbury.Continuing with the African music sound, Amadou & Mariam are preceded by a performance from Ibibio Sound Machine, who combine London electronic music with Nigerian funk and pop sounds.
- Bailey Lauerman's 'Choose Wisely' Campaign For The Effies
Friday Oct 6, 2017
The campaign incorporates animation to illustrate the insights and ideas that happen along the way to creating work.
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- The Link Between Huntington’s Disease and Brain Structure
Wednesday Sep 6, 2017
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These finding may explain the causes of the debilitating symptoms and loss of brain tissue as the disease progresses. Currently, it is not understood why the mutation of a specific gene leads to expression of symptoms and loss -